Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 23-33, 2023.
Article in English | WPRIM | ID: wpr-968508

ABSTRACT

Purpose@#The incidence and prevalence of inflammatory bowel disease (IBD) are increasing along with an increasing number of patients with comorbid conditions like psychiatric and behavioral disorders, which are independent predictors of quality of life. @*Methods@#Non-overlapping years (2003-2016) of National Inpatient Sample and Kids Inpatient Database were analyzed to include all IBD-related hospitalizations of patients less than 21 years of age. Patients were analyzed for a concomitant diagnosis of psychiatric/ behavioral disorders and were compared with IBD patients without psychiatric/behavioral disorder diagnoses for outcome variables: IBD severity, length of stay and inflation-adjusted hospitalization charges. @*Results@#Total of 161,294 IBD-related hospitalizations were analyzed and the overall prevalence rate of any psychiatric and behavioral disorders was 15.7%. Prevalence rate increased from 11.3% (2003) to 20.6% (2016), p<0.001. Depression, substance use, and anxiety were the predominant psychiatric disorders. Regression analysis showed patients with severe IBD (odds ratio [OR], 1.57; confidence interval [CI], 1.47–1.67; p<0.001) and intermediate IBD (OR, 1.14; CI, 1.10–1.28, p<0.001) had increased risk of associated psychiatric and behavioral disorders than patients with a low severity IBD. Multivariate analysis showed that psychiatric and behavioral disorders had 1.17 (CI, 1.07–1.28; p<0.001) mean additional days of hospitalization and incurred additional $8473 (CI, 7,520–9,425; p<0.001) of mean hospitalization charges, independent of IBD severity. @*Conclusion@#Prevalence of psychiatric and behavioral disorders in hospitalized pediatric IBD patients has been significantly increasing over the last two decades, and these disorders were independently associated with prolonged hospital stay, and higher total hospitalization charges.

2.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 61-69, 2022.
Article in English | WPRIM | ID: wpr-918690

ABSTRACT

Purpose@#Studies in adults have shown an increasing incidence of Clostridioides difficile infection (CDI) in patients hospitalized with acute pancreatitis (AP). There is lack of epidemiological data on CDI and its impact on hospitalized pediatric patients with AP. @*Methods@#We analyzed the National Inpatient Sample and Kids' Inpatient Database between the years 2003 and 2016 and included all patients (age <21 years) with a primary diagnosis of AP using specific International Classification of Diseases codes. We compared clinical outcomes between children with CDI and those without CDI. Our primary outcome was severe AP and secondary outcomes included length of stay and hospital charges. @*Results@#A total of 123,240 hospitalizations related to AP were analyzed and CDI was noted in 0.6% of the hospital. The prevalence rate of CDI doubled from 0.4% (2003) to 0.8% (2016), p=0.03. AP patients with CDI had increased comorbidities, and also underwent more invasive surgical procedures, p<0.05. AP patients with CDI had a higher in-hospital mortality rate and increased prevalence of severe AP, p<0.001. Multivariate regression models showed that CDI was associated with 2.4 times (confidence interval [CI]: 1.91 to 3.01, p<0.001) increased odds of severe AP. CDI patients had 7.24 (CI: 6.81 to 7.67, p<0.001) additional hospital days while incurring $59,032 (CI: 54,050 to 64,014, p<0.001) additional hospitalization charges. @*Conclusion@#CDI in pediatric patients with AP is associated with adverse clinical outcomes and increased healthcare resource utilization. Further studies are needed to elucidate this association to prevent the development of CDI and to improve outcomes.

3.
Article | IMSEAR | ID: sea-201202

ABSTRACT

Background: Genetic predisposition plays a critical role in the incidence of type 2 diabetes mellitus (T2DM). While a few reports strongly associate TCF7L2 gene polymorphisms in the T2DM incidence in India, data pertaining to the prevalence of these polymorphisms in the south Tamil Nadu population has been lacking. Hence, the present study aims to determine the prevalence and association of the TCF7L2 gene variants rs7903146, rs12255372 in the regional population of south Tamil Nadu.Methods: Peripheral blood samples from controls, T2DM patients were utilized to isolate genomic DNA and genotyping was carried out using PCR based strategies, direct sequencing. Socio-demographic details, anthropometric measurements, determination of postprandial, random blood glucose levels and oral glucose tolerance test (OGTT) were further carried out to evaluate the predisposition risk for T2DM.Results: 50% of the control group participants and 73.9% of the T2DM patients were positive (CT/TT) for the TCF7L2 polymorphism rs7903146. The rs12255372 SNP was less prevalent in the controls, patients and was dispersed in only 25% of the controls and 60.9% (GT/TT) of the patients. The 60 minutes plasma glucose levels for the oral glucose tolerance test (OGTT) was higher (143.3±19.8) in the rs7903146 and rs12255372 positive control participants.Conclusions: The study results reveal that TCF7L2 polymorphisms are dispersed in the regional population and further large scale, long term follow up studies will aid preventive and therapeutic measures in T2DM.

4.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 527-535, 2019.
Article in English | WPRIM | ID: wpr-760889

ABSTRACT

PURPOSE: There is increasing prevalence of psychiatric disorders among inflammatory bowel Disease (IBD) population. Further, presence of psychiatric disorders has been shown as an independent predictor of quality of life among patients with IBD. We intended to explore the prevalence of various psychiatric disorders among pediatric and young adult population with IBD as a population-based analysis. METHODS: We did a retrospective case control analysis using a deidentified cloud-based database including health care data across 26 health care networks comprising of more than 360 hospitals across USA. Data collected across different hospitals were classified and stored according to Systematized Nomenclature of Medicine-Clinical Terms. We preidentified 10 psychiatric disorders and the queried the database for the presence of at least one of the ten psychiatric disorders among IBD patients between 5 and 24 years of age and compared with controls. RESULTS: Total of 11,316,450 patients in the age group between 5 and 24 years and the number of patients with a diagnosis of IBD, Crohn's disease or ulcerative colitis were 58,020. The prevalence of psychiatric disorders was 21.6% among IBD mainly comprising of depression and anxiety disorder. Multiple logistic regression analysis showed, IBD is 5 times more likely associated with psychiatric disorders than controls, p<0.001). We showed a steady increasing trend in the incidence of psychiatric disorders among IBD patients (2% in 2006 to 15% in 2017). CONCLUSION: Largest population-based analysis demonstrated an increased prevalence of psychiatric disorders among IBD patients. Our study emphasizes the need for psychological and mental health services to be incorporated as a part of the routine IBD clinic.


Subject(s)
Humans , Young Adult , Adjustment Disorders , Anxiety , Anxiety Disorders , Case-Control Studies , Colitis, Ulcerative , Crohn Disease , Delivery of Health Care , Depression , Diagnosis , Incidence , Inflammatory Bowel Diseases , Logistic Models , Mental Health Services , Prevalence , Quality of Life , Retrospective Studies
5.
Article in English | IMSEAR | ID: sea-180660

ABSTRACT

Background. Alcohol use is common in many cultures. Excessive use of alcohol adversely impacts individuals, families and communities. Medicine, which uses biomedical models and perspectives, views alcohol dependence as a disease. Alcohol use and dependence are complex societal problems, which need to be viewed through multidisciplinary approaches and corrected by adopting intersectoral efforts involving local communities. Methods. We used qualitative methods such as focus group discussions and in-depth interviews to document perspectives on alcohol use among a tribal community in southern India. We recorded traditional norms, changing patterns of use of alcohol and its consequences for individuals, families and the community. Results. Eight focus group discussions and eleven in-depth interviews were conducted. Though consumption of alcohol is part of the local culture, changes in occupation and availability of alcohol has made its consumption a problem. The introduction and easy availability of Indian-made foreign liquor, which is stronger than the locally brewed variety, in government-run outlets has changed the culture of drinking at festivals to drinking more often. This leads to public fights, domestic violence and increasing mortality and morbidity due to road traffic incidents and ill health. The age of initiation into drinking has decreased. Conclusion. The introduction of non-traditional and commercial alcohol use has put a heavy price on tribal and rural people. Community-based interventions targeting young children and adolescents may pay more dividends than pursuing purely medical treatments for problem drinkers.

6.
Hamdard Medicus. 2010; 53 (3): 15-18
in English | IMEMR | ID: emr-146345

ABSTRACT

Extracts of the leaves of Chromolaena odorata [L.] King and Robinson were subjected to preliminary phytochemical screening for the presence of plant secondary metabolites and in vitro antibacterial and antiftmgal studies. The results of preliminary study revealed the presence of alkaloids, steroidal nucleus, flavonoids, saponins and tannins in the ethanol and chloroform extracts. The chloroform and alcohol extracts were investigated for in vitro antibacterial and antifungal activities by using Agar Disc Diffusion Technique. Four strains of micro-organisms comprising two gram positive, one gram negative and one fungi were used in this study. The results of minimum inhibitory concentration [MIC] study revealed the antimicrobial activity and antifungal activity of the extract against the tested strains of microorganisms in concentration ranges of 25, 50 and 75 microg/ml, respectively. The results of zone of inhibition study revealed the concentration dependent nature of the extracts with better effectiveness against gram positive bacteria than gram negative bacteria

7.
Hamdard Medicus. 2009; 52 (3): 122-131
in English | IMEMR | ID: emr-109794

ABSTRACT

The different parts of the plant, Ervataniia coronaria have different uses in the traditional system of medicine. The plant is used as anodyne, anthelmintic, vermicide, anti-inflammatory[1], hepato-protective[2] and also in the treatment of skin and eye diseases. The present study i.e., pharmacognostical and phytochemical studies include macroscopic, microscopic evaluation Physical and chemical evaluation. All the procedures were done as per WHO guidelines[3]


Subject(s)
Pharmacognosy , Anti-Infective Agents , Plant Leaves , Phytotherapy
SELECTION OF CITATIONS
SEARCH DETAIL